GR3021221T3 - Piperazine derivatives - Google Patents
Piperazine derivativesInfo
- Publication number
- GR3021221T3 GR3021221T3 GR960402575T GR960402575T GR3021221T3 GR 3021221 T3 GR3021221 T3 GR 3021221T3 GR 960402575 T GR960402575 T GR 960402575T GR 960402575 T GR960402575 T GR 960402575T GR 3021221 T3 GR3021221 T3 GR 3021221T3
- Authority
- GR
- Greece
- Prior art keywords
- piperazine derivatives
- rsqbstr
- lsqbstr
- phenylbutyryl
- azepin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909022820A GB9022820D0 (en) | 1990-10-19 | 1990-10-19 | Piperazine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3021221T3 true GR3021221T3 (en) | 1997-01-31 |
Family
ID=10684053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960402575T GR3021221T3 (en) | 1990-10-19 | 1996-10-02 | Piperazine derivatives |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0481744B1 (el) |
JP (1) | JP3007203B2 (el) |
KR (1) | KR100193928B1 (el) |
AT (1) | ATE143012T1 (el) |
AU (1) | AU642044B2 (el) |
CA (1) | CA2053709C (el) |
DE (1) | DE69122205T2 (el) |
DK (1) | DK0481744T3 (el) |
ES (1) | ES2091879T3 (el) |
GB (2) | GB9022820D0 (el) |
GR (1) | GR3021221T3 (el) |
HU (2) | HU212943B (el) |
IE (1) | IE65379B1 (el) |
NZ (1) | NZ240271A (el) |
PT (1) | PT99251B (el) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9125900D0 (en) * | 1991-12-05 | 1992-02-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
AU675964B2 (en) * | 1992-08-05 | 1997-02-27 | John Wyeth & Brother Limited | Amide derivatives |
GB9221931D0 (en) * | 1992-10-17 | 1992-12-02 | Wyeth John & Brother Ltd | Piperazine derivatives |
GB2271930B (en) * | 1992-11-03 | 1996-07-24 | Wyeth John & Brother Ltd | Pharmaceutical piperazine derivatives |
GB9223153D0 (en) * | 1992-11-05 | 1992-12-16 | Wyeth John & Brother Ltd | Piperazine derivatives |
GB9303968D0 (en) * | 1993-02-26 | 1993-04-14 | Wyeth John & Brother Ltd | 5-ht1a ligands |
GB9304632D0 (en) * | 1993-03-06 | 1993-04-21 | Wyeth John & Brother Ltd | Amide derivatives |
US5609849A (en) * | 1994-03-11 | 1997-03-11 | The Trustees Of The University Of Pennsylvania | Serotonin (5-HT1A) receptor ligands and imaging agents |
GB9419024D0 (en) * | 1994-09-21 | 1994-11-09 | Wyeth John & Brother Ltd | Bicyclic carboxamides |
GB9525239D0 (en) * | 1995-12-09 | 1996-02-07 | American Home Prod | Medical treatment |
FR2744448B1 (fr) * | 1996-02-02 | 1998-04-24 | Pf Medicament | Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments |
US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
ITMI20021327A1 (it) * | 2002-06-14 | 2003-12-15 | Recordati Chem Pharm | Nuove ossialchilpiperazine |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2776282A (en) * | 1954-05-04 | 1957-01-01 | Searle & Co | Cyclic amides of alpha-toluic acids and derivatives thereof |
GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
FI102175B1 (fi) * | 1989-04-22 | 1998-10-30 | Wyeth John & Brother Ltd | Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten valmistamiseksi |
AU644488B2 (en) * | 1990-10-19 | 1993-12-09 | John Wyeth & Brother Limited | Piperazine derivatives |
-
1990
- 1990-10-19 GB GB909022820A patent/GB9022820D0/en active Pending
-
1991
- 1991-09-02 GB GB9118744A patent/GB2248836B/en not_active Expired - Fee Related
- 1991-10-16 DE DE69122205T patent/DE69122205T2/de not_active Expired - Fee Related
- 1991-10-16 ES ES91309513T patent/ES2091879T3/es not_active Expired - Lifetime
- 1991-10-16 EP EP91309513A patent/EP0481744B1/en not_active Expired - Lifetime
- 1991-10-16 AT AT91309513T patent/ATE143012T1/de not_active IP Right Cessation
- 1991-10-16 DK DK91309513.9T patent/DK0481744T3/da active
- 1991-10-17 NZ NZ240271A patent/NZ240271A/xx unknown
- 1991-10-17 PT PT99251A patent/PT99251B/pt active IP Right Grant
- 1991-10-17 JP JP3269290A patent/JP3007203B2/ja not_active Expired - Fee Related
- 1991-10-17 AU AU85920/91A patent/AU642044B2/en not_active Ceased
- 1991-10-18 IE IE366991A patent/IE65379B1/en not_active IP Right Cessation
- 1991-10-18 CA CA002053709A patent/CA2053709C/en not_active Expired - Fee Related
- 1991-10-18 KR KR1019910018373A patent/KR100193928B1/ko not_active IP Right Cessation
- 1991-10-18 HU HU913292A patent/HU212943B/hu not_active IP Right Cessation
-
1995
- 1995-06-27 HU HU95P/P00447P patent/HU211587A9/hu unknown
-
1996
- 1996-10-02 GR GR960402575T patent/GR3021221T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GB2248836A (en) | 1992-04-22 |
PT99251A (pt) | 1992-08-31 |
PT99251B (pt) | 1999-04-30 |
ATE143012T1 (de) | 1996-10-15 |
EP0481744A1 (en) | 1992-04-22 |
IE913669A1 (en) | 1992-04-22 |
GB2248836B (en) | 1994-05-04 |
DE69122205T2 (de) | 1997-01-30 |
HU212943B (en) | 1996-12-30 |
AU8592091A (en) | 1992-04-30 |
EP0481744B1 (en) | 1996-09-18 |
GB9022820D0 (en) | 1990-12-05 |
ES2091879T3 (es) | 1996-11-16 |
CA2053709A1 (en) | 1992-04-20 |
IE65379B1 (en) | 1995-10-18 |
JP3007203B2 (ja) | 2000-02-07 |
HU211587A9 (en) | 1995-12-28 |
NZ240271A (en) | 1993-03-26 |
HUT60264A (en) | 1992-08-28 |
GB9118744D0 (en) | 1991-10-16 |
JPH04282371A (ja) | 1992-10-07 |
HU913292D0 (en) | 1992-01-28 |
CA2053709C (en) | 2001-12-11 |
AU642044B2 (en) | 1993-10-07 |
KR920008019A (ko) | 1992-05-27 |
DK0481744T3 (da) | 1996-10-07 |
KR100193928B1 (ko) | 1999-06-15 |
DE69122205D1 (de) | 1996-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2248836B (en) | Piperazine derivatives | |
AU674477B2 (en) | Heterocyclic-cyclic amine derivatives | |
OA09521A (en) | Heterocyclic N-oxide derivatives of substituted benzo 5,6 cycloheptapyridines compositions and methods of use | |
IE823067L (en) | Piperidinedione derivatives | |
SI0707007T1 (en) | (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent | |
GR3020369T3 (en) | Xanthine derivatives | |
AU644051B2 (en) | Piperidine derivatives | |
HUP9904167A3 (en) | 1,4-disubstituted piperazine and piperidine derivatives, their use and pharmaceutical compositions containing the same | |
EP0276543A3 (en) | Use of buspirone for the improvement of short term memory | |
ATE116316T1 (de) | Antipsychotische 4-(1,2- benzisoazolyl)piperidinderivate. | |
NO903640D0 (no) | Fremgangsmaate for fremstilling av 2-(rs)-substituerte 2,3-dihydro-5-oksy-4,6,7-trimetylbenzofuraner. | |
IE812069L (en) | Azaspirodecanediones | |
NZ216750A (en) | Morpholino derivatives and fungicides | |
HU9202914D0 (en) | 4-(4-(4-hydroxiphenyl)-1-piperazinyl)-5-methyl-3h-1,2,4-triazole-3-one derivatives | |
MY110446A (en) | Piperazine derivatives | |
EP0333676A3 (en) | Use of 1-(2-ethoxy-2-(3'-pyridyl)ethyl)-4-(2'methoxy-phenyl)piperazine, for the preparation of pharmaceutical compositions useful for the treatment of lower urinary tract disfunctions and benign prostatic hypertrophy | |
MX9201297A (es) | Derivados piperacinicos y procedimiento para su preparacion. | |
ES2149691A1 (es) | 2-4-[4-(4,5-dicloro-2metilimidazol-1-il)butil]-1-piperacinil -5-fluoropirimidina, su preparacion y su utilizacion terapeutica. | |
PL298827A1 (en) | Novel enantiomers derivatives of (s)-2-amino(3,4-dichlorobenzyl) propanol-1 | |
AU5128096A (en) | Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them | |
MX9604201A (es) | Nuevos derivados de piperidina. | |
FI98728B (fi) | Menetelmä terapeuttisesti käyttökelpoisen 2,3,4,5,6,7-heksahydro-1-(4- 1-/4-(2-metoksifenyyli)piperatsinyyli/ -2-fenyylibutyryyli)-1H-atsepiinin tai sen farmaseuttisesti hyväksyttävän happoadditiosuolan valmis tamiseksi |